Agreement - February 23, 2022
Zerion Pharma and Hovione enter strategic partnership
Zerion Pharma has entered into a strategic partnership with Hovione to accelerate the commercialization of the Dispersome technology. Through their partnership, the two companies are offering pharma and biotech companies worldwide access to an innovative drug delivery platform combined with an unparalleled experience in formulation development, scale up and GMP manufacturing, they state. This combination […]
In a new job - November 14, 2020
Zerion appoints CFO and Director of regulatory affairs
ZERION announces the appointment of Jakob Dynnes Hansen as Chief Financial Officer and Mónica González Heredia as Director of Regulatory Affairs. Both joined ZERION’s management team in October 2020. “In an ambitious biotech company as ZERION, the team is the most important and I am both excited and grateful that we have been able to […]
Biotech Business - October 1, 2020
ZERION receives 1.9 million DKK from the Danish Innovation Fund
The Danish Innovation Fund has awarded the drug delivery company a grant of DKK 1.9 million under its InnoBooster program. The grant will advance the development of ZERION’s Dispersome drug formulations. The InnoBooster grant covers about one third of the total project costs. “We are extremely grateful to receive this support from the Innovation Fund. […]